IBM closed at $210.50, down 1.17%.
Recent options activity featured a significant, multi-million dollar call sale, highlighting a notable bearish premium collection strategy as the dominant flow for the session.
>>>Click to claim your commission-free cards before trading!
Options Indicators
IBM’s implied volatility is 49.47%, and with an IV percentile of 92.43%, current option volatility sits in a clearly elevated regime, indicating options are priced expensively relative to their own historical range. At the same time, the IV/HV ratio of 0.44 suggests implied volatility is running below realized volatility, which tempers the usual “rich premium” reading somewhat, but the dominant takeaway is still that the market is assigning IBM options a high relative volatility pricing backdrop.
The Call/Put volume ratio is 2.67.
Large Trades
A CALL sale worth $3.66 million was the standout large trade in IBM, with 1,500 contracts sold against the June 17, 2027 $250.00 strike. With IBM referenced at $210.50, this call sits out of the money, making it a bearish-to-neutral premium-selling position rather than an immediately directional upside bet. By selling upside exposure at a strike well above the current share price, the trader appears to be expressing the view that IBM is unlikely to rally beyond $250.00 by expiration, while collecting option premium as income.
Overall sentiment in IBM’s large-trade flow was bearish. Total bullish activity was $0.00 million, while total bearish activity reached $3.66 million, leaving a net difference of $3.66 million to the bearish side. The tone of the flow suggests a market participant willing to sell upside risk rather than position for further appreciation, indicating restrained expectations for IBM’s upside and a sentiment profile that leans clearly bearish.
Strategy Reference
For traders aiming to sell premium with a low probability of assignment, a call credit spread targeting a higher out-of-the-money strike like $260.00 could be considered to define risk and reduce margin requirements.